W. R. Berkley news
The WiseView Research desk's stories that name W. R. Berkley, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The WRB page →
- HeadlineW. R. Berkley: 3 Key Takeaways for Long-Term Investors
- HeadlineW.R. Berkley Q3 Earnings Beat, Revenues Miss, Premiums Rise Y/Y
- HeadlineThese Analysts Revise Their Forecasts On WR Berkley Following Q3 Results
- HeadlineW. R. Berkley: A Strong Insurer At A Full Valuation
- HeadlineW. R. Berkley Corporation (WRB) Q3 2026 Earnings Call Transcript
- HeadlineW.R. Berkley Q3 Earnings Call Highlights
- HeadlineW.R. Berkley (WRB) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
- HeadlineW.R. Berkley (WRB) Tops Q3 Earnings Estimates
- HeadlineW. R. Berkley Corporation Reports Third Quarter 2026 Results
- HeadlineI'd Turn $100,000 Into $6,200 A Year Of Retirement Income
- HeadlineIs a Beat in the Cards for W.R. Berkley This Earnings Season?
- HeadlineStay Ahead of the Game With W.R. Berkley (WRB) Q3 Earnings: Wall Street's Insights on Key Metrics
- HeadlineWhy W.R. Berkley (WRB) is a Top Value Stock for the Long-Term
- HeadlineW.R. Berkley (WRB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- HeadlineWR Berkley Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
- HeadlineHere's Why W.R. Berkley (WRB) is a Strong Momentum Stock
- CongressRo Khanna bought $1,001 - $15,000 of WRB
- CongressGilbert Cisneros sold $1,001 - $15,000 of WRB
- CongressGilbert Cisneros sold $1,001 - $15,000 of WRB
- CongressGilbert Cisneros sold $1,001 - $15,000 of WRB
- CongressGilbert Cisneros sold $1,001 - $15,000 of WRB
- CongressGilbert Cisneros sold $1,001 - $15,000 of WRB
- CongressGilbert Cisneros sold $1,001 - $15,000 of WRB
- CongressGilbert Cisneros sold $1,001 - $15,000 of WRB
Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.